Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants

NCT00291967 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

525

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Hepatitis B
Hib Diseases
Neisseria Meningitidis Serogroups A & C Diseases

Interventions

BIOLOGICAL: DTPw-HBV/Hib-MenAC conjugate vaccine

Sponsor

GlaxoSmithKline